Jean‐Pierre Desager
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Hepatology top 5%
Papers in
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 10
- Pharmacology and Obesity Treatment 5
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Diabetes Treatment and Management 4
- Co-authors
- Jean‐Luc Balligand (3 shared papers)Olivier Féron (3 shared papers)Chantal Dessy (3 shared papers)Yves Horsmans (11 shared papers)Stéphane Moniotte (1 shared paper)Isabelle Leclercq (6 shared papers)C. Harvengt (11 shared papers)Nathalie M. Delzenne (2 shared papers)
In The Last Decade
Jean‐Pierre Desager
46 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 115
- Pharmacology 334
- Hepatology 210
- Endocrinology, Diabetes and Metabolism 334
- Cardiology and Cardiovascular Medicine 429
- Biochemistry 124
Countries citing papers authored by Jean‐Pierre Desager
This map shows the geographic impact of Jean‐Pierre Desager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Desager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Desager more than expected).
Fields of papers citing papers by Jean‐Pierre Desager
This network shows the impact of papers produced by Jean‐Pierre Desager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Desager. The network helps show where Jean‐Pierre Desager may publish in the future.
Co-authors
The 25 scholars most cited alongside Jean‐Pierre Desager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 338 | |
| 2 | 1999 | 325 | |
| 3 | 1995 | 220 | |
| 4 | 2005 | 195 | |
| 5 | 2003 | 147 | |
| 6 | 1996 | 145 | |
| 7 | 2003 | 115 | |
| 8 | 2003 | 96 | |
| 9 | 1998 | 58 | |
| 10 | 1994 | 55 | |
| 11 | 1998 | 54 | |
| 12 | 2003 | 52 | |
| 13 | 1996 | 46 | |
| 14 | 1985 | 41 | |
| 15 | Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias. | 1980 | 40 |
| 16 | 1980 | 38 | |
| 17 | 1998 | 37 | |
| 18 | 1995 | 33 | |
| 19 | 1998 | 29 | |
| 20 | 1988 | 25 |
About Jean‐Pierre Desager
Jean‐Pierre Desager is a scholar working on Pharmacology, Pharmacology, Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology, having authored 48 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Liver Disease Diagnosis and Treatment (6 papers), Lipoproteins and Cardiovascular Health (6 papers), Epilepsy research and treatment (5 papers), Pharmacology and Obesity Treatment (5 papers), Analytical Methods in Pharmaceuticals (4 papers), Diabetes Treatment and Management (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Pharmacology (334 citations), Hepatology (210 citations), Endocrinology, Diabetes and Metabolism (334 citations), Cardiology and Cardiovascular Medicine (429 citations) and Biochemistry (124 citations). Jean‐Pierre Desager has collaborated with scholars based in Belgium, Australia and Germany. Frequent co-authors include Jean‐Luc Balligand, Olivier Féron, Chantal Dessy, Yves Horsmans, Yves Horsmans, Stéphane Moniotte, Isabelle Leclercq, C. Harvengt, Nathalie M. Delzenne and Nadine Kok. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Clinical Pharmacokinetics, Journal of Hepatology, Hepatology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.